MICHAEL BRAUN to Immunohistochemistry
This is a "connection" page, showing publications MICHAEL BRAUN has written about Immunohistochemistry.
Connection Strength
0.290
-
Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial. J Immunother Cancer. 2021 05; 9(5).
Score: 0.132
-
C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice. J Am Soc Nephrol. 2005 Dec; 16(12):3572-82.
Score: 0.045
-
HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN. Breast Cancer Res. 2025 Feb 14; 27(1):22.
Score: 0.043
-
Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells. J Immunol. 2004 Sep 15; 173(6):4190-6.
Score: 0.042
-
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease. Am J Kidney Dis. 2019 02; 73(2):218-229.
Score: 0.028